A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use.
- DOI
- 10.1007/s40263-026-01302-y
- Published
- 2026 Aug
- Container
- CNS drugs
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40263-026-01302-y,
title = {A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use.},
author = {Merenlender Wagner A and Perlstein I and Farkas P and Lamson M and Loupe P and Spiegelstein O and Kalmanczhelyi A and Tiver R and Franzenburg KR and Harary E and Elgart A},
year = {2026},
journal = {CNS drugs},
doi = {10.1007/s40263-026-01302-y},
url = {https://doi.org/10.1007/s40263-026-01302-y}
}RIS
TY - JOUR TI - A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use. AU - Merenlender Wagner A AU - Perlstein I AU - Farkas P AU - Lamson M AU - Loupe P AU - Spiegelstein O AU - Kalmanczhelyi A AU - Tiver R AU - Franzenburg KR AU - Harary E AU - Elgart A PY - 2026 JO - CNS drugs DO - 10.1007/s40263-026-01302-y UR - https://doi.org/10.1007/s40263-026-01302-y ER -
APA
A, M. W., I, P., P, F., M, L., P, L., O, S., A, K., R, T., KR, F., E, H., & A, E. (2026). A Phase 1 Open-Label Study Assessing the Safety and Pharmacokinetics of TV-46000, an Extended-Release Injectable Suspension of Risperidone for Subcutaneous Use.. CNS drugs. https://doi.org/10.1007/s40263-026-01302-y
Source records
- pubmed · retrieved 2026-09-26T10:05:30.253Z